Cerebral
small
vessel
disease
(CSVD)
plays
a
significant
role
in
the
development
of
lacunar
strokes
and
is
closely
associated
with
cognitive
decline,
gait
disturbances,
vascular
dementia.
This
systematic
review
explores
pathophysiology
management
CSVD,
focus
on
its
contribution
to
stroke
recurrence
patient
outcomes.
Key
findings
indicate
that
structural
cardiac
abnormalities,
inflammatory
markers,
metabolic
disorders
are
critical
predictors
risk
individuals
CSVD.
Structural
changes
heart,
such
as
altered
left
ventricular
geometry,
linked
higher
rates,
while
elevated
like
high-sensitivity
C-reactive
protein,
increased
events.
Metabolic
conditions,
particularly
diabetes,
correlate
more
severe
abnormalities
heightened
recurrent
mortality.
Notably,
some
treatment
strategies,
dual
antiplatelet
therapy,
may
inadvertently
increase
mortality
specific
groups,
underscoring
importance
individualized
therapeutic
approaches.
These
insights
emphasize
multifactorial
nature
CSVD
highlight
need
for
comprehensive
assessments
targeted
strategies
improve
clinical
Cardiovascular Diabetology,
Год журнала:
2023,
Номер
22(1)
Опубликована: Ноя. 15, 2023
Abstract
Diabetes
microangiopathy,
a
hallmark
complication
of
diabetes,
is
characterised
by
structural
and
functional
abnormalities
within
the
intricate
network
microvessels
beyond
well-known
documented
target
organs,
i.e.,
retina,
kidney,
peripheral
nerves.
Indeed,
an
intact
microvascular
bed
crucial
for
preserving
each
organ’s
specific
functions
achieving
physiological
balance
to
meet
their
respective
metabolic
demands.
Therefore,
diabetes-related
dysfunction
leads
widespread
multiorgan
consequences
in
still-overlooked
non-traditional
organs
such
as
brain,
lung,
bone
tissue,
skin,
arterial
wall,
heart,
or
musculoskeletal
system.
All
these
are
vulnerable
physiopathological
mechanisms
that
cause
damage
diabetes
(i.e.,
hyperglycaemia-induced
oxidative
stress,
inflammation,
endothelial
dysfunction)
collectively
contribute
microvessels’
structure
function,
compromising
blood
flow
tissue
perfusion.
However,
microcirculatory
networks
differ
between
due
variations
haemodynamic,
vascular
architecture,
affected
cells,
resulting
spectrum
clinical
presentations.
The
aim
this
review
focus
on
multifaceted
nature
impairment
through
available
evidence
often
overlooked
organs.
A
better
understanding
microangiopathy
non-target
provides
broader
perspective
systemic
disease,
underscoring
importance
recognising
comprehensive
range
complications
classic
sites.
Journal of Integrative Neuroscience,
Год журнала:
2025,
Номер
24(2)
Опубликована: Фев. 19, 2025
Cerebral
small
vessel
disease
is
a
common
endangering
human
health
due
to
its
insidious
and
repeated
onset
progressive
aggravation.
White
matter
hyperintensities
(WMHs)
are
one
of
the
classic
imaging
markers
cerebral
disease.
The
term
'WMHs'
was
first
proposed
by
Hachinski
in
1987.
WMHs
our
study
mainly
refer
white
damage
caused
various
vascular
factors,
known
as
vascularized
hyperintensity.
significantly
correlated
with
stroke,
cognitive
dysfunction,
emotional
disturbance,
gait
abnormality,
have
drawn
widespread
attention.
This
article
reviews
research
progress
on
pathogenesis
dysfunction
associated
provides
theoretical
reference
for
understanding
early
assessment
dysfunction.
Frontiers in Cellular Neuroscience,
Год журнала:
2023,
Номер
17
Опубликована: Июнь 2, 2023
Ceramide,
a
bioactive
sphingolipid,
serves
as
an
important
second
messenger
in
cell
signal
transduction.
Under
stressful
conditions,
it
can
be
generated
from
de
novo
synthesis,
sphingomyelin
hydrolysis,
and/or
the
salvage
pathway.
The
brain
is
rich
lipids,
and
abnormal
lipid
levels
are
associated
with
variety
of
disorders.
Cerebrovascular
diseases,
which
mainly
caused
by
cerebral
blood
flow
secondary
neurological
injury,
leading
causes
death
disability
worldwide.
There
growing
body
evidence
for
close
connection
between
elevated
ceramide
cerebrovascular
especially
stroke
small
vessel
disease
(CSVD).
increased
has
broad
effects
on
different
types
cells,
including
endothelial
microglia,
neurons.
Therefore,
strategies
that
reduce
such
modifying
sphingomyelinase
activity
or
rate-limiting
enzyme
synthesis
pathway,
serine
palmitoyltransferase,
may
represent
novel
promising
therapeutic
approaches
to
prevent
treat
injury-related
diseases.
Journal of Inflammation Research,
Год журнала:
2023,
Номер
Volume 16, С. 311 - 319
Опубликована: Янв. 1, 2023
Background:
White
matter
hyperintensity
(WMH)
is
associated
with
risk
of
acute
ischemic
stroke
(AIS)
and
poor
outcomes
after
AIS.
The
purpose
this
prospective
study
was
to
evaluate
the
association
between
serum
YKL-40
levels
WMH
burden
in
patients
Methods:
From
February
2020
March
2021,
a
total
672
consecutive
AIS
magnetic
resonance
imaging
data
were
prospectively
recruited
form
two
centers.
Serum
quantified
using
enzyme-linked
immunosorbent
assay.
semiquantitatively
measured
by
Fazekas
visual
grading
scale.
According
severity
overall
WMH,
dichotomized
into
none–mild
group
(Fazekas
score
0–
2)
or
moderate–severe
3–
6).
Besides,
based
on
periventricular
(PV-WMH)
deep
(D-WMH),
categorized
as
1)
2–
3).
Results:
Among
patients,
335
(49.9%)
participants
identified
326
(48.5%)
PV-WMH
262
(39.0%)
D-WMH.
Compared
first
quartile
YKL-40,
adjusted
odds
ratio
(OR)
fourth
for
2.473
(95%
confidence
interval
[CI]
1.316–
4.646;
P
=0.005).
No
significant
observed
(OR
0.762;
95%
CI
0.434–
1.336;
=0.343)
D-WMH
0.695;
0.413–
1.171;
=0.172).
Conclusion:
Our
results
suggested
that
higher
appeared
be
PV-WMH,
but
not
Keywords:
stroke,
white
hyperintensities,
biomarkers
Biomedicines,
Год журнала:
2024,
Номер
12(7), С. 1463 - 1463
Опубликована: Июль 1, 2024
Globally,
cerebral
microbleeds
(CMBs)
are
increasingly
being
viewed
not
only
as
a
marker
for
small
vessel
disease
(SVD)
but
also
having
an
increased
risk
the
development
of
stroke
(hemorrhagic/ischemic)
and
aging-related
dementia.
Recently,
brain
endothelial
cell
activation
dysfunction
blood–brain
barrier
and/or
disruption
have
been
shown
to
be
associated
with
SVD,
enlarged
perivascular
spaces,
evolution
CMBs.
CMBs
known
disorder
microvessels
that
visualized
3–5
mm,
smooth,
round,
or
oval,
hypointense
(black)
lesions
seen
on
T2*-weighted
gradient
recall
echo
susceptibility-weighted
sequences
MRI
images.
occur
high
prevalence
in
community-dwelling
older
individuals.
Since
our
current
global
population
is
oldest
recorded
history
expected
continue
grow,
we
can
expect
healthcare
burdens
grow.
Increased
numbers
(≥10)
should
raise
red
flag
regarding
large
symptomatic
neurologic
intracerebral
hemorrhages.
Importantly,
currently
regarded
markers
diffuse
vascular
neurodegenerative
damage.
Herein
author
highlights
it
essential
learn
much
about
CMB
development,
evolution,
their
relation
impaired
cognition,
dementia,
exacerbation
neurodegeneration.
Stroke,
Год журнала:
2023,
Номер
54(5), С. 1367 - 1376
Опубликована: Апрель 24, 2023
Structural
network
damage
is
a
potentially
important
mechanism
by
which
cerebral
small
vessel
disease
(SVD)
can
cause
cognitive
impairment.
As
central
hub
of
the
structural
network,
role
thalamus
in
SVD-related
impairments
remains
unclear.
We
aimed
to
determine
associations
between
alterations
thalamic
subregions
and
SVD.In
this
cross-sectional
study,
205
SVD
participants
without
lacunes
from
third
follow-up
(2020)
prospective
RUN
DMC
study
(Radboud
University
Nijmegen
Diffusion
Tensor
Magnetic
Resonance
Cohort),
was
initiated
2006,
Nijmegen,
were
included.
Cognitive
functions
included
processing
speed,
executive
function,
memory.
Probabilistic
tractography
performed
6
cortical
regions,
followed
connectivity-based
segmentation
assess
each
subregion
volume
connectivity
(measured
mean
diffusivity
[MD]
connecting
white
matter
tracts)
with
cortex.
Least
absolute
shrinkage
selection
operator
regression
analysis
conducted
identify
volumes
or
total
that
have
strongest
association
performance.
Linear
mediation
analyses
test
least
operator-selected
MD
performance,
while
adjusting
for
age
education.We
found
higher
thalamic-motor
tract
associated
worse
speed
(β=-0.27;
P<0.001),
thalamic-frontal
function
(β=-0.24;
P=0.001),
memory
(β=-0.28;
respectively.
The
showed
thalamocortical
tracts
mediated
corresponding
performances
3
domains.Our
results
suggest
are
linked
impairment
SVD,
largely
depending
on
pattern
specific
regions.
Regenerative Therapy,
Год журнала:
2024,
Номер
25, С. 377 - 386
Опубликована: Фев. 22, 2024
Cerebral
small
vessel
disease
(CSVD),
as
the
most
common,
chronic
and
progressive
vascular
on
brain,
is
a
serious
neurological
disease,
whose
pathogenesis
remains
unclear.
The
leading
cause
of
stroke
cognitive
impairment
dementia,
contributes
to
about
20%
strokes,
including
25%
ischemic
strokes
45%
dementias.
Undoubtedly,
high
incidence
poor
prognosis
CSVD
have
brought
heavy
economic
medical
burden
society.
present
treatment
focuses
management
risk
factors.
Although
factors
may
be
important
causes
or
accelerators
should
always
treated
in
accordance
with
best
clinical
practice,
controlling
alone
could
not
curb
progression
brain
injury.
Therefore,
developing
safer
more
effective
strategies
for
urgently
needed.
Recently,
mesenchymal
stem
cells
(MSCs)
therapy
has
become
an
emerging
therapeutic
modality
central
nervous
system
given
their
paracrine
properties
immunoregulatory.
Herein,
we
discussed
potential
MSCs
CSVD,
aiming
enable
clinicians
researchers
understand
recent
progress
future
directions
field.
Abstract
Cerebral
microbleed(s)
(CMBs)
are
increasingly
being
viewed
not
only
as
a
marker
for
cerebral
small
vessel
disease
(SVD)
but
also
having
an
increased
risk
the
development
of
stroke
(hemorrhagic/ischemic)
and
aging-related
dementia.
Recently,
brain
endothelial
cell
activation
dysfunction
blood-brain
barrier
and/or
disruption
have
been
shown
to
be
associated
with
SVD,
enlarged
perivascular
spaces,
evolution
CMBs.
CMBs
known
disorder
microvessels
that
visualized
3-5mm,
smooth,
round
or
oval,
hypointense
(black)
lesions
seen
on
T2*-weighted
gradient
recall
echo
susceptibility-weighted
sequences
MRI
images.
(a
global
problem)
occur
high
prevalence
in
community-dwelling
older
individuals.
Since
our
current
population
is
oldest
recorded
history
expected
continue
grow,
we
can
expect
health
care
burdens
grow.
should
raise
red
flag
regarding
large
symptomatic
neurologic
intracerebral
hemorrhages.
Importantly,
currently
regarded
markers
diffuse
vascular
neurodegenerative
damage.
Thus,
it
essential
try
learn
much
about
their
development,
evolution,
relation
impaired
cognition,
dementia,
neurodegeneration.
CNS Neuroscience & Therapeutics,
Год журнала:
2023,
Номер
30(3)
Опубликована: Сен. 18, 2023
Abstract
Background
and
Objective
Inflammation
has
emerged
as
a
prominent
risk
factor
for
cerebral
small
vessel
disease
(CSVD).
However,
the
specific
association
between
various
inflammatory
biomarkers
development
of
CSVD
remains
unclear.
Serine
proteinase
inhibitor
A3
(SERPINA3),
Matrix
metalloproteinase‐9
(MMP‐9),
Tissue
metalloproteinase‐1
(TIMP‐1),
Monocyte
Chemoattractant
Protein‐1
(MCP‐1)
are
several
that
potentially
involved
in
CSVD.
In
this
present
study,
we
aimed
to
investigate
relationship
candidate
molecules
features.
Method
The
concentration
each
biomarker
was
measured
79
acute
ischemic
stroke
patients
admitted
within
72
h
after
symptom
onset.
associations
blood
levels
markers
score
were
investigated,
well
feature,
including
white
matter
hyperintensities
(WMH),
lacunes,
enlarged
perivascular
spaces
(EPVS).
Results
mean
age
69.0
±
11.8
years,
65.8%
participants
male.
Higher
SERPINA3
level
(>78.90
ng/mL)
significantly
associated
with
larger
WMH
volume
higher
scores
on
Fazekas's
scale
all
three
models.
Multiple
regression
analyses
revealed
linear
absolute
burden
level,
especially
model
3
(
β
=
0.14;
95%
confidence
interval
[CI],
0.04–0.24
p
).
Restricted
cubic
spline
demonstrated
dose–response
nonlineariy
0.0366
0.0378
2
mode
3,
respectively).
Using
receiving
operating
characteristic
(ROC)
curve,
plasma
64.15
ng/mL
distinguished
>7.8
mL
highest
sensitivity
specificity
(75.92%
60%,
respectively,
area
under
curve
[AUC]
0.668,
0.0102).
No
statistically
significant
been
found
other
Conclusion
summary,
among
four
at
baseline
severity,
which
novel
validated
its
inflammation
endothelial
dysfunction.